Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of OCUL will rise by +7.79% over the next 2 Weeks and hit $10.65 by Monday, July 27, 2026. In that time frame, OCUL's share price is expected to range between $10.24 and $11.04.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 27, 2026 | 10.24 | 10.65 | 11.04 |
| Jul 24, 2026 | 10.26 | 10.67 | 11.06 |
| Jul 23, 2026 | 10.26 | 10.67 | 11.07 |
| Jul 22, 2026 | 10.10 | 10.50 | 10.90 |
| Jul 21, 2026 | 10.06 | 10.47 | 10.92 |
| Jul 20, 2026 | 9.91 | 10.34 | 10.74 |
| Jul 17, 2026 | 9.96 | 10.36 | 10.80 |
| Jul 16, 2026 | 9.95 | 10.36 | 10.79 |
| Jul 15, 2026 | 9.80 | 10.19 | 10.62 |
| Jul 14, 2026 | 9.75 | 10.16 | 10.58 |
OCUL shares fell -3.14% in Monday, July 13, 2026's trading session, dropping from a previous close of $10.20 to move at $9.88. The stock demonstrated notable intraday movement (see OCUL's key stats for a full breakdown), fluctuating between $9.76 and $10.19, a +4.35% trading range. While recent weeks have seen some volatility, OCUL has managed to secure a -0.20% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.44M shares changing hands, 438.99K fewer than the previous session. This amounted to $14.19M in total market activity.
Will OCUL Continue Its Upward Trend?
According to analyst ratings and projections for OCUL, Ocular Therapeutix, Inc. shares are anticipated to increase by +10.48%, potentially reaching $11.04 per share by July 27, 2026. Short-term technical indicators currently suggest a neutral sentiment for OCUL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the OCUL stock forecast, now is a good time to buy OCUL stock because its current trading price is -7.23% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on OCUL covering social and institutional perspectives.
OCUL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into OCUL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.60% to 54.38%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.57%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.24%, maintains a neutral outlook for the long term. Insights into OCUL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Ocular Therapeutix Short-Term Forecasts
OCUL Forecast For Next 5 Days
Our algorithm anticipates Ocular Therapeutix (OCUL) stock could hit $10.02 by Jul 20, 2026. This represents a +1.37% rise from today's price, following a +7.11% change over the past five days.
OCUL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Ocular Therapeutix, Inc. (OCUL) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $10.52, which would mean a +6.48% increase from the current price of $9.88. Projections for this period range from a high of $12.00 to a low of $9.41.
OCUL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Ocular Therapeutix's price over the next three months point to a rise. OCUL stock is expected to peak at $25.35 on Sep 18, 2026 before potentially dipping to $20.72 on Oct 13, 2026. On average, OCUL is likely to trade around $22.79 in the coming 90 days.
Ocular Therapeutix Stock Forecast 2025
Based on our predictive models, Ocular Therapeutix (OCUL) is expected to trade between $17.32 and $29.14 throughout 2026. This would result in an average price of $22.83, potentially offering investors a +131.07% return from current levels.
Ocular Therapeutix, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Ocular Therapeutix, Inc. (OCUL) is positioned to show a strong performance in July 2026. The price is predicted to move between $22.19 and $24.12, settling at an average of $23.33. This could translate to a +136.13% gain.
August 2026
Based on current market signals, Ocular Therapeutix, Inc. is projected to trend august 2026. We forecast a trading range from $20.76 to $23.00, with a likely average price of $21.60. Investors could expect a potential return of +118.62%.
September 2026
Our predictive algorithms indicate Ocular Therapeutix, Inc. stock may see a shift in September 2026. The expected range spans $21.27–$25.35, with an average target of $23.40. This represents a positive outlook and a possible gain of +136.84%.
October 2026
Analyzing established trends, Ocular Therapeutix, Inc. looks set to move in October 2026. Projections place the stock between $20.42 and $24.80, averaging around $22.34. This suggests a +126.11% gain from current levels.
November 2026
Market indicators suggest Ocular Therapeutix, Inc. could experience notable changes during November 2026. Prices could fluctuate within $19.99 to $26.30, with a midpoint forecast of $22.32. The stock might deliver a +125.91% gain.
December 2026
Forecasting for December 2026, models estimate that Ocular Therapeutix, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $17.32 and $29.14, averaging $24.02. This signals a positive trajectory with potential returns around +143.12%.
January 2027
According to our latest forecast models, Ocular Therapeutix, Inc. (OCUL) is positioned to show a strong performance in January 2027. The price is predicted to move between $12.36 and $24.68, settling at an average of $18.28. This could translate to a +85.02% gain.
February 2027
Based on current market signals, Ocular Therapeutix, Inc. is projected to trend february 2027. We forecast a trading range from $11.84 to $25.16, with a likely average price of $17.61. Investors could expect a potential return of +78.24%.
March 2027
Our predictive algorithms indicate Ocular Therapeutix, Inc. stock may see a shift in March 2027. The expected range spans $8.38–$27.14, with an average target of $16.90. This represents a positive outlook and a possible gain of +71.05%.
April 2027
Analyzing established trends, Ocular Therapeutix, Inc. looks set to move in April 2027. Projections place the stock between $8.28 and $25.27, averaging around $16.54. This suggests a +67.41% gain from current levels.
May 2027
Market indicators suggest Ocular Therapeutix, Inc. could experience notable changes during May 2027. Prices could fluctuate within $5.95 to $25.34, with a midpoint forecast of $15.95. The stock might deliver a +61.44% gain.
June 2027
Forecasting for June 2027, models estimate that Ocular Therapeutix, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $4.66 and $26.87, averaging $14.97. This signals a positive trajectory with potential returns around +51.52%.
July 2027
According to our latest forecast models, Ocular Therapeutix, Inc. (OCUL) is positioned to show a strong performance in July 2027. The price is predicted to move between $5.01 and $34.71, settling at an average of $18.86. This could translate to a +90.89% gain.
OCUL's history of dividends and stock splits also plays a role in long-term investor confidence.

